학술논문
Safety, pharmacokinetics, and antiviral activity of RO7049389, a core protein allosteric modulator, in patients with chronic hepatitis B virus infection: a multicentre, randomised, placebo-controlled, phase 1 trial
Document Type
Article
Author
Source
In The Lancet Gastroenterology & Hepatology September 2021 6(9):723-732
Subject
Language
ISSN
2468-1253